Learn to track real recovery in major depressive disorder by monitoring mood, energy, cognition, and quality of life for ...
CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal ...
Major depressive disorder is linked to Th2 immune dysregulation similar to atopic dermatitis. Could dupilumab offer a new ...
A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of ...
Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, ...
Could a smart watch act as an early-warning system for depression relapse? New research from McMaster University suggests ...
DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...
MILAN — Psilocybin leads to a better overall outcome in the treatment of moderate to severe major depressive disorder (MDD) than the selective serotonin reuptake inhibitor (SSRI) escitalopram, results ...
Older adults with major depressive disorder (MDD) exhibit riskier driving behaviors than their nondepressed peers, including hard braking, cornering, and unpredictable driving patterns, new research ...